Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
Bogani G, Matteucci L, Tamberi S, Ditto A, Sabatucci I, Murgia F, Arcangeli V, Maltese G, Comerci G, Stefanetti M, Sonetto C, Calareso G, Marchiano A, Chiappa V, Lorusso D, Raspagliesi F. Bogani G, et al. Among authors: matteucci l. Eur J Obstet Gynecol Reprod Biol. 2019 Jun;237:93-99. doi: 10.1016/j.ejogrb.2019.04.007. Epub 2019 Apr 8. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31029972
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.
Bogani G, Matteucci L, Tamberi S, Arcangeli V, Ditto A, Maltese G, Signorelli M, Martinelli F, Chiappa V, Leone Roberti Maggiore U, Perotto S, Scaffa C, Comerci G, Stefanetti M, Raspagliesi F, Lorusso D. Bogani G, et al. Among authors: matteucci l. Int J Gynecol Cancer. 2017 Nov;27(9):1856-1862. doi: 10.1097/IGC.0000000000001108. Int J Gynecol Cancer. 2017. PMID: 29064913
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study.
Raspagliesi F, Bogani G, Matteucci L, Casarin J, Sabatucci I, Tamberi S, Arcangeli V, Maltese G, Lepori S, Comerci G, Stefanetti M, Ditto A, Martinelli F, Chiappa V, Lorusso D. Raspagliesi F, et al. Among authors: matteucci l. Int J Gynecol Cancer. 2018 Nov;28(9):1706-1713. doi: 10.1097/IGC.0000000000001286. Int J Gynecol Cancer. 2018. PMID: 30376554
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies.
Passardi A, Rapposelli IG, Scarpi E, Sullo FG, Bartolini G, Neri E, Ghigi G, Tontini L, Ercolani G, Monti M, Ruscelli S, Matteucci L, Valgiusti M, Frassineti GL, Romeo A. Passardi A, et al. Among authors: matteucci l. Biomolecules. 2021 Aug 12;11(8):1200. doi: 10.3390/biom11081200. Biomolecules. 2021. PMID: 34439866 Free PMC article.
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5-Fluorouracil in the FOLFIRI Regimen.
Passardi A, Monti M, Donati C, Foca F, Pagan F, Rapposelli I, Ruscelli S, Bartolini G, Valgiusti M, Matteucci L, Sullo F, Sbaffi S, Crudi L, Frassineti GL, Masini C. Passardi A, et al. Among authors: matteucci l. Oncologist. 2021 Aug;26(8):e1314-e1319. doi: 10.1002/onco.13762. Epub 2021 Apr 22. Oncologist. 2021. PMID: 33764600 Free PMC article.
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
Casadei Gardini A, Scarpi E, Valgiusti M, Monti M, Ruscelli S, Matteucci L, Bartolini G, Vertogen B, Pagan F, Rovesti G, Frassineti GL, Passardi A. Casadei Gardini A, et al. Among authors: matteucci l. Ther Adv Med Oncol. 2020 Sep 28;12:1758835920958363. doi: 10.1177/1758835920958363. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33062063 Free PMC article.
Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature.
Monti M, Cortesi P, Vespignani R, Bronico I, Gallio C, Flospergher M, Matteucci L, Frassineti GL. Monti M, et al. Among authors: matteucci l. Front Oncol. 2022 May 26;12:875391. doi: 10.3389/fonc.2022.875391. eCollection 2022. Front Oncol. 2022. PMID: 35692777 Free PMC article.
Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
Lilli C, Biggeri A, Zingaretti C, Vertogen B, Frassineti V, Vespignani R, Grossi V, Florescu C, Matteucci L, Pazzi C, Bongiovanni A, Limarzi F, Fausti V, Bertoni L, Donati C, Galardi F, Gentili N, Mazza F, Martinelli G, Nanni O. Lilli C, et al. Among authors: matteucci l. Epidemiol Prev. 2021 Jan-Apr;45(1-2):28-36. doi: 10.19191/EP21.1-2.P028.036. Epidemiol Prev. 2021. PMID: 33884840 Free article. Clinical Trial. English.
48 results